Detalles de la búsqueda
1.
Real-world burden of adverse events for apalutamide- or enzalutamide-treated non-metastatic castration-resistant prostate cancer patients in the United States.
BMC Cancer
; 22(1): 304, 2022 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35317768
2.
Clinical outcomes, management, and treatment patterns in patients with metastatic castration-resistant prostate cancer treated with radium-223 in community compared to academic settings.
Prostate
; 81(10): 657-666, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33978244
3.
Follicular lymphoma treatment patterns between 2000 and 2014: a SEER-Medicare analysis of elderly patients.
Future Oncol
; 16(8): 353-365, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32043384
4.
Physician preferences for non-metastatic castration-resistant prostate cancer treatment.
BMC Urol
; 20(1): 73, 2020 Jun 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32571276
5.
Next-Generation Sequencing Trends among Adult Patients with Select Advanced Tumor Types: A Real-World Evidence Evaluation.
J Mol Diagn
; 26(4): 292-303, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38296192
6.
Drug-drug interaction potential among patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) treated with novel androgen receptor inhibitors.
Expert Rev Anticancer Ther
; 24(5): 325-333, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38469875
7.
Adverse events and costs among non-metastatic castration-resistant prostate cancer patients.
J Med Econ
; 27(1): 145-152, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38174553
8.
Survival Outcomes by Race and Ethnicity in Veterans With Nonmetastatic Castration-Resistant Prostate Cancer.
JAMA Netw Open
; 6(10): e2337272, 2023 10 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37819658
9.
Treatment Patterns of Follicular Lymphoma in the United States: A Claims Analysis.
J Health Econ Outcomes Res
; 9(2): 115-122, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36348725
10.
Budget impact analysis of darolutamide for treatment of nonmetastatic castration-resistant prostate cancer.
J Manag Care Spec Pharm
; 27(2): 166-174, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33141615
11.
Treatment of metastatic castration resistant prostate cancer with radium-223: a retrospective study at a US tertiary oncology center.
Prostate Cancer Prostatic Dis
; 24(1): 210-219, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32814846
12.
A Retrospective Claims Analysis of Advanced Prostate Cancer Costs and Resource Use.
Pharmacoecon Open
; 4(3): 439-447, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31641995
13.
Survival benefit associated with treating follicular lymphoma in patients 80 years or older.
J Geriatr Oncol
; 11(1): 55-61, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31706831
14.
Patient-level Factors Associated With the Initial Management of Older Adults Diagnosed With Follicular Lymphoma: A Surveillance, Epidemiology, and End Results-Medicare Analysis.
Clin Lymphoma Myeloma Leuk
; 20(4): e184-e194, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31956071
15.
Patient and caregiver benefit-risk preferences for nonmetastatic castration-resistant prostate cancer treatment.
Cancer Med
; 9(18): 6586-6596, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32725755
16.
Costs associated with follicular lymphoma among individuals diagnosed with non-Hodgkin lymphoma: a longitudinal analysis using SEER-Medicare data.
Leuk Lymphoma
; 61(1): 75-83, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31389296
17.
Costs and Healthcare Resource Utilization Associated with Hospital Admissions of Patients with Metastatic or Nonmetastatic Prostate Cancer.
Am Health Drug Benefits
; 12(6): 306-312, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31908714
18.
A Budget Impact Analysis of the Introduction of Copanlisib for Treatment of Relapsed Follicular Lymphoma in the United States.
J Manag Care Spec Pharm
; 25(4): 437-446, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30608008
Resultados
1 -
18
de 18
1
Próxima >
>>